Literature DB >> 15719613

Trials for preparation of inactivated sheep pox vaccine using binary ethyleneimine.

Manal Awad1, A Michael, Soad M Soliman, S S Samir, A M Daoud.   

Abstract

Binary ethyleneimine (BEI) was used to inactivate the local Egyptian strain of sheep pox virus. The inactivation process was applied using final concentrations of BEI at 0.5, 1, 2 and 3% for different incubation periods at 37 degrees C. The virus was completely inactivated after 7 hours incubation with by 2% BEI final concentration; the inactivated virus was adsorbed on aluminium hydroxide gel when incubated for 6 hours in a concentration 1:1. The antibody levels were estimated by virus neutralization test and ELISA. Specific antibodies appeared from the 1st week post vaccination and remained until the 4th week post challenge. The prepared vaccine was evaluated for safety, sterility and potency. The vaccine proved to be safe, sterile and inducing protection for the vaccinated lambs when challenged by the virulent sheep pox virus up to 6 months post vaccination.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15719613

Source DB:  PubMed          Journal:  Egypt J Immunol


  4 in total

1.  Comparative innocuity and efficacy of live and inactivated sheeppox vaccines.

Authors:  Zineb Boumart; Samira Daouam; Imane Belkourati; Lamya Rafi; Eeva Tuppurainen; Khalid Omari Tadlaoui; Mehdi El Harrak
Journal:  BMC Vet Res       Date:  2016-06-29       Impact factor: 2.741

2.  Development of a Safe and Highly Efficient Inactivated Vaccine Candidate against Lumpy Skin Disease Virus.

Authors:  Janika Wolff; Tom Moritz; Kore Schlottau; Donata Hoffmann; Martin Beer; Bernd Hoffmann
Journal:  Vaccines (Basel)       Date:  2020-12-23

Review 3.  Capripoxvirus Infections in Ruminants: A Review.

Authors:  Jihane Hamdi; Henry Munyanduki; Khalid Omari Tadlaoui; Mehdi El Harrak; Ouafaa Fassi Fihri
Journal:  Microorganisms       Date:  2021-04-23

4.  Improved safety profile of inactivated Neethling strain of the Lumpy Skin Disease Vaccine.

Authors:  Matome Selina Matsiela; Leeann Naicker; Vusi Saul Dibakwane; Nomfundo Ntombela; Thandeka Khoza; Nobalanda Mokoena
Journal:  Vaccine X       Date:  2022-08-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.